Resmed Inc. buy Needham & Company LLC
Start price
01.04.24
/
50%
€177.75
Target price
01.04.25
€207.72
Performance (%)
15.33%
End price
02.04.25
€205.00
Summary
This prediction ended on 02.04.25 with a price of €205.00. The prediction had a final performance of 15.33%. Dividends of €1.93 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.512% | -2.512% | -9.382% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten